Suarez, JI: Hypertonic Saline for Cerebral Edema

Total Page:16

File Type:pdf, Size:1020Kb

Suarez, JI: Hypertonic Saline for Cerebral Edema Hypertonic saline for cerebral edema and elevated intracranial pressure JOSE´ I. SUAREZ, MD erebral edema and elevated intracranial movements. Because transport through the BBB is a pressure (ICP) are important and frequent selective process, the osmotic gradient that a particle problems in the neurocritically ill patient. can create is also dependent on how restricted its They can both result from various insults permeability through the barrier is. This restriction is C expressed in the osmotic reflection coefficient, which to the brain. Improving cerebral edema and decreas- ing ICP has been associated with improved out- ranges from 0 (for particles that can diffuse freely) to come.1 However, all current treatment modalities 1.0 (for particles that are excluded the most effec- are far from perfect and are associated with serious tively and therefore are osmotically the most active). adverse events:1–4 indiscriminate hyperventilation The reflection coefficient for sodium chloride is can lead to brain ischemia; mannitol can cause 1.0 (mannitol’s is 0.9), and under normal conditions intravascular volume depletion, renal insufficiency, sodium (Na+) has to be transported actively into the and rebound ICP elevation; barbiturates are associat- CSF.5,6 Animal studies have shown that in condi- ed with cardiovascular and respiratory depression tions of an intact BBB, CSF Na+ concentrations and prolonged coma; and cerebrospinal fluid (CSF) increase when an osmotic gradient exists but lag drainage via intraventricular catheter insertion may behind plasma concentrations for 1 to 4 hours.5 result in intracranial bleeding and infection. Thus, elevations in serum Na+ will create an effec- Other treatment modalities have been explored, tive osmotic gradient and draw water from brain into and hypertonic saline (HS) solutions particularly the intravascular space. appear to be an appealing addition to the current therapeutic avenues for cerebral edema. This article Cerebral edema and intracranial dynamics succinctly reviews some of the basic concepts and Cerebral edema is defined as an increase in brain 7 mechanisms of action of HS and discusses some of water leading to an increase in total brain mass. its possible clinical applications. There are three major categories of brain edema: • Vasogenic edema, which is caused by increased ■ PHYSIOLOGIC CONTEXT permeability of the endothelial cells of brain capil- laries and is seen in patients with brain neoplasms The blood-brain barrier • Cytotoxic edema, which results from the influx of The blood-brain barrier (BBB) represents both an water into cells. This type of edema may be caused anatomic and a physiologic structure. The BBB is by energy depletion with failure of the ATP-depen- made up of tight junctions between the endothelial dent Na+-K+ pump (ie, cerebral infarction) or low cells of the cerebral capillaries.5 Various mechanisms extracellular Na+ content (ie, hyponatremia). exist for compounds to cross the BBB, including • Interstitial edema, in which CSF diffuses through active transport, diffusion, and carrier-mediated the ependymal lining of the ventricles into the periventricular white matter. This type of edema is seen with hydrocephalus. From the Department of Neurology and Neurosurgery, Uni- versity Hospitals of Cleveland and Case Western Reserve It is important to point out that different types of University, Cleveland, Ohio. edema can coexist in the same patient. For instance, Address: Jose´ I. Suarez, MD, Department of Neurology, Uni- brain ischemia is associated with both cytotoxic and versity Hospitals of Cleveland, 11100 Euclid Avenue, vasogenic edema. Cleveland, OH 44106; e-mail:[email protected]. The presence of cerebral edema, with the subse- CLEVELAND CLINIC JOURNAL OF MEDICINE VOLUME 71 • SUPPLEMENT 1 JANUARY 2004 S9 SUAREZ ■ HYPERTONIC SALINE quent increase in brain mass, alters the intracranial • Restoration of normal membrane potentials contents (brain, blood, and CSF). Small increases through normalization of intracellular sodium and in brain volume can be compensated by changes in chloride concentrations.13 CSF volume and venous blood volume. Beyond • Reduction of extravascular lung volume, lead- 15 that, changes in intracranial volume (ΔICV) will ing to improved gas exchange and improved PaO2. result in changes in ICP (ΔICP), which has been termed compliance (ΔICV/ΔICP). When brain ■ EXPERIMENTAL SUPPORT FOR THE EFFICACY compliance decreases, such as when intracranial OF HYPERTONIC SALINE volume rises, ICP rises.8 However, it is important to realize that focal cerebral edema can create ICP gra- Animal studies dients and cause tissue shifts in the absence of a HS solutions have been studied extensively in a global increase in ICP.1 variety of animal models, as thoroughly detailed in a recent review.13 The literature suggests that fluid ■ HYPERTONIC SALINE: MECHANISMS OF ACTION resuscitation with an HS bolus after hemorrhagic shock prevents the ICP increase that follows resus- HS solutions can possibly affect the volume of the citation with standard colloid and crystalloid fluids intracranial structures through various mechanisms. for 2 hours or less. This effect can be maintained for All or several of them are likely to be interacting to longer periods by using a continuous HS infusion. achieve the end result of HS therapy: reduction of HS may be superior to colloid solutions with regard cerebral edema and elevated ICP. These mecha- to ICP response during the initial period of resusci- nisms are summarized below: tation.16,17 In animal models of cerebral injury, the • Dehydration of brain tissue by creation of an maximal ICP-reducing effect of HS is appreciated osmotic gradient, thus drawing water from the with focal lesions, such as cryogenic injury or intra- parenchyma into the intravascular space. As men- cerebral hemorrhage. Again, the ICP reduction may tioned above, this would require an intact BBB. be caused by reduction in water content in areas of Experimental evidence suggests that the brain the brain with the BBB intact, such as the nonle- water–reducing properties of HS are accomplished sioned hemisphere and the cerebellum. HS has also at the expense of the normal hemisphere. been compared with mannitol and was found to • Reduced viscosity. HS solutions enhance intra- have equal efficacy in reducing ICP but to have a vascular volume and reduce viscosity.9 The autoreg- longer duration of action and to yield greater ulatory mechanisms of the brain vasculature have improvement in cerebral perfusion pressure.13 been shown to respond not only to changes in blood pressure but also to changes in viscosity.10 Thus, a Human studies decrease in blood viscosity results in vasoconstric- Despite the numerous studies in animal models, tion in order to maintain a stable cerebral blood most of the evidence in humans is based on the pub- flow (CBF). lication of case series and a few randomized studies. • Increased plasma tonicity. It has been postulated, Some of the published studies are briefly reviewed based on experimental animal data, that increased here. Readers are referred to a recent review13 for a plasma tonicity, such as that seen after HS adminis- more detailed description. tration, favors more rapid absorption of CSF.11 Acute ischemic stroke. HS in two different con- • Increased regional brain tissue perfusion, possi- centrations, 7.5% and 10%, has been used to reduce bly secondary to dehydration of cerebral endothelial ICP in patients after large cerebral infarcts.18,19 cells and erythrocytes, facilitating flow through cap- Schwarz et al18 compared the effect of 100 mL of illaries.12 7.5% HS hydroxyethyl starch (osmolarity 2,570 • Increased cardiac output and mean arterial blood mosm/L) and 200 mL of 20% mannitol (osmolarity pressure, with resultant augmentation of cerebral 1,100 mosm/L) in 9 patients with stroke randomized perfusion pressure, most likely due to improvement to one of the two treatments. HS hydroxyethyl of plasma volume and a positive inotropic effect.9,13 starch caused a greater and earlier peak reduction in • Diminished inflammatory response to brain ICP, although mannitol caused more improvement injury, which has been demonstrated with HS in cerebral perfusion pressure. These same administration.14 researchers studied the effect of 10% saline bolus S10 CLEVELAND CLINIC JOURNAL OF MEDICINE VOLUME 71 • SUPPLEMENT 1 JANUARY 2004 SUAREZ ■ HYPERTONIC SALINE infusions in 8 patients in whom mannitol had have reported on the use of HS in patients with var- failed.19 HS reduced ICP by at least 10% in all the ious intracranial pathologies.34–37 instances it was used, and the maximal effect was Gemma et al34 performed a prospective, random- noted at 20 minutes after the end of the infusion. ized comparison of 2.5 mL/kg of 20% mannitol and Even though ICP rose subsequently, it did not reach 7.5% saline in patients undergoing elective supra- pretreatment values during the 4 hours of data tentorial procedures. They found that the two treat- recording. ments had similar effects on CSF pressure and on Intracranial hemorrhage. There has been one clinical assessment of brain bulk. However, the report of 2 patients with nontraumatic (presumably administered solutions used were not equiosmolar. hypertensive) intracranial hemorrhage who were In a retrospective study, Qureshi et al35 determined treated with continuous HS infusion.20 Both the effect of continuous 3% saline/acetate infusion patients improved clinically after 24 hours of treat- on ICP and lateral displacement of the brain in ment but deteriorated at 48 and 96 hours despite patients with cerebral edema and a variety of under- continued HS infusion. Repeat CT scanning lying cerebral lesions. The authors found a reduction showed extension of edema. These findings were in mean ICP within the first 12 hours, correlating attributed to a rebound effect similar to that with an increase in serum sodium concentration, in described with mannitol. patients with traumatic brain injury and postopera- Subarachnoid hemorrhage. Two studies have tive edema, but not in patients with nontraumatic been published on the effect of HS on clinical intracranial hemorrhage or cerebral infarction.
Recommended publications
  • Case Report of Hyperacute Edema and Cavitation Following Deep Brain Stimulation Lead Implantation Albert J
    www.surgicalneurologyint.com Surgical Neurology International Editor-in-Chief: Nancy E. Epstein, MD, Clinical Professor of Neurological Surgery, School of Medicine, State U. of NY at Stony Brook. SNI: Stereotactic Editor Veronica Lok-Sea Chiang, MD Yale School of Medicine, New Haven, CT, USA Open Access Case Report Case report of hyperacute edema and cavitation following deep brain stimulation lead implantation Albert J. Fenoy1,2, Christopher R. Conner2, Joseph S. Withrow2, Aaron W. Hocher2 Movement Disorders and Neurodegenerative Disease Program, Departments of 1Neurology, 2Neurosurgery, McGovern Medical School, Houston, Texas, United States. E-mail: *Albert J. Fenoy - [email protected]; Christopher R. Conner - [email protected]; Joseph S. Withrow - joseph.s.withrow@ uth.tmc.edu; Aaron W. Hocher - [email protected] ABSTRACT Background: Postoperative cerebral edema around a deep brain stimulation (DBS) electrode is an uncommonly reported complication of DBS surgery. e etiology of this remains unknown, and the presentation is highly variable; however, the patients generally report a good outcome. Case Description: Here, we report an unusual presentation of postoperative edema in a 66-year-old female *Corresponding author: who has bilateral dentatorubrothalamic tract (specifically, the ventral intermediate nucleus) DBS for a mixed Albert J. Fenoy, type tremor disorder. Initial postoperative computed tomography (CT) was unremarkable and the patient was Department of Neurosurgery, admitted for observation. She declined later on postoperative day (POD) 1 and became lethargic. Stat head CT McGovern Medical School, scan performed revealed marked left-sided peri-lead edema extending into the centrum semiovale with cystic 6431 Fannin St., Houston, Texas cavitation, and trace right-sided edema.
    [Show full text]
  • Neurologic Complications of Electrolyte Disturbances and Acid–Base Balance
    Handbook of Clinical Neurology, Vol. 119 (3rd series) Neurologic Aspects of Systemic Disease Part I Jose Biller and Jose M. Ferro, Editors © 2014 Elsevier B.V. All rights reserved Chapter 23 Neurologic complications of electrolyte disturbances and acid–base balance ALBERTO J. ESPAY* James J. and Joan A. Gardner Center for Parkinson’s Disease and Movement Disorders, Department of Neurology, UC Neuroscience Institute, University of Cincinnati, Cincinnati, OH, USA INTRODUCTION hyperglycemia or mannitol intake, when plasma osmolal- ity is high (hypertonic) due to the presence of either of The complex interplay between respiratory and renal these osmotically active substances (Weisberg, 1989; function is at the center of the electrolytic and acid-based Lippi and Aloe, 2010). True or hypotonic hyponatremia environment in which the central and peripheral nervous is always due to a relative excess of water compared to systems function. Neurological manifestations are sodium, and can occur in the setting of hypovolemia, accompaniments of all electrolytic and acid–base distur- euvolemia, and hypervolemia (Table 23.2), invariably bances once certain thresholds are reached (Riggs, reflecting an abnormal relationship between water and 2002). This chapter reviews the major changes resulting sodium, whereby the former is retained at a rate faster alterations in the plasma concentration of sodium, from than the latter (Milionis et al., 2002). Homeostatic mech- potassium, calcium, magnesium, and phosphorus as well anisms protecting against changes in volume and sodium as from acidemia and alkalemia (Table 23.1). concentration include sympathetic activity, the renin– angiotensin–aldosterone system, which cause resorption HYPONATREMIA of sodium by the kidneys, and the hypothalamic arginine vasopressin, also known as antidiuretic hormone (ADH), History and terminology which prompts resorption of water (Eiskjaer et al., 1991).
    [Show full text]
  • Neurologic Disease Session Guidelines
    Neurologic Disease Session Guidelines This is a 15 minute webinar session for CNC physicians and staff CNC holds webinars monthly to address topics related to risk adjustment documentation and coding Next scheduled webinar: • June • Topic: Factors Influencing Health CNC does not accept responsibility or liability for any adverse outcome from this training for any reason including undetected inaccuracy, opinion, and analysis that might prove erroneous or amended, or the coder/physician’s misunderstanding or misapplication of topics. Application of the information in this training does not imply or guarantee claims payment. Agenda Neuropathy Parkinson's Disease Epilepsy Plegia/Paresis Other Neurologic Disease Key Documentation Elements Neuropathy The neuropathies listed below are associated with a HCC diagnosis: Inflammatory polyneuropathy Polyneuropathy that is due to alcohol, toxic agents, critical illness, radiation or drug induced Polyneuropathy in diseases classified elsewhere Document and code the other disease, such as amyloidosis, endocrine disease, metabolic disease, neoplasm, vitamin or nutritional deficiencies Neuropathy Risk Factors for development of Peripheral Neuropathy • Diabetes • Chemotherapy • HIV/AIDS • Autoimmune Disease • Chronic Inflammatory Demyelinating Polyneuropathy • Stress • Alcohol Abuse • Vitamin Deficiency • Genetic Diseases • Toxic Substances Parkinson’s Disease Parkinson’s disease is a HCC diagnosis, whether the condition is idiopathic, drug induced or a result of infectious or other external agents. Four Main Motor Symptoms 1. Shaking or tremor Parkinson's disease (PD) is a neurodegenerative brain disorder that 2. Slowness of movement, progresses slowly in most people. called bradykinesia 3. Stiffness or rigidity of the Parkinson's disease itself is not fatal. However, complications from arms, legs or trunk the disease are serious; the Centers for Disease Control and 4.
    [Show full text]
  • Early Seizures and Cerebral Edema After Trivial Head Trauma Associated
    Early seizures and cerebral edema after trivial head trauma associated with the CACNA1A S218L mutation Anine H Stam, Gert Jan Luijckx, Bwee Tien Poll-The, Ieke Ginjaar, Rune R Frants, Joost Haan, Michel D Ferrari, Gisela M Terwindt, Arn M J M van den Maagdenberg To cite this version: Anine H Stam, Gert Jan Luijckx, Bwee Tien Poll-The, Ieke Ginjaar, Rune R Frants, et al.. Early seizures and cerebral edema after trivial head trauma associated with the CACNA1A S218L mutation. Journal of Neurology, Neurosurgery and Psychiatry, BMJ Publishing Group, 2009, 80 (10), pp.1125. 10.1136/jnnp.2009.177279. hal-00552784 HAL Id: hal-00552784 https://hal.archives-ouvertes.fr/hal-00552784 Submitted on 6 Jan 2011 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Early seizures and cerebral edema after trivial head trauma associated with the CACNA1A S218L mutation 1* 2* 3* Anine H. Stam, MD , Gert-Jan Luijckx, MD, PhD , Bwee Tien Poll-Thé, MD, PhD Ieke B. Ginjaar, PhD4, Rune R. Frants, PhD5, Joost Haan, MD, PhD1,6, Michel D. Ferrari, MD, PhD1, Gisela M. Terwindt, MD, PhD1, Arn M.J.M.
    [Show full text]
  • Diagnosis and Treatment of Cerebrospinal Fluid Rhinorrhea Following Accidental Traumatic Anterior Skull Base Fractures
    Neurosurg Focus 32 (6):E3, 2012 Diagnosis and treatment of cerebrospinal fluid rhinorrhea following accidental traumatic anterior skull base fractures MATEO ZIU, M.D., JENNIFER GENTRY SAVAGE, M.D., AND DAVID F. JIMENEZ, M.D. Department of Neurosurgery, University of Texas Health Science Center at San Antonio, Texas Cerebrospinal fluid rhinorrhea is a serious and potentially fatal condition because of an increased risk of menin- gitis and brain abscess. Approximately 80% of all cases occur in patients with head injuries and craniofacial fractures. Despite technical advances in the diagnosis and management of CSF rhinorrhea caused by craniofacial injury through the introduction of MRI and endoscopic extracranial surgical approaches, difficulties remain. The authors review here the pathophysiology, diagnosis, and management of CSF rhinorrhea relevant exclusively to traumatic anterior skull base injuries and attempt to identify areas in which further work is needed. (http://thejns.org/doi/abs/10.3171/2012.4.FOCUS1244) KEY WORDS • craniomaxillofacial trauma • head trauma • cerebrospinal fluid rhinorrhea • meningitis • dural repair • endoscopic surgery • skull base fracture EREBROSPINAL fluid rhinorrhea is a serious and po- Furthermore, the issues related to CSF leak caused tentially fatal condition that still presents a major by traumatic injury are complex and multiple. Having challenge in terms of its diagnosis and manage- conducted a thorough review of existing literature, we Cment. It is estimated that meningitis develops in approxi- discuss here the pathophysiology, diagnosis, and man- mately 10%–25% of patients with this disorder, and 10% agement of CSF rhinorrhea relevant to traumatic anterior of them die as a result. Approximately 80% of all cases of skull base injuries and attempt to identify areas in which CSF rhinorrhea are caused by head injuries that are asso- further research is needed.
    [Show full text]
  • Contemporary Approach to the Diagnosis and Management of Cerebrospinal Fluid Rhinorrhea
    REVIEWS AND CONTEMPORARY UPDATES Ochsner Journal 16:136–142, 2016 Ó Academic Division of Ochsner Clinic Foundation Contemporary Approach to the Diagnosis and Management of Cerebrospinal Fluid Rhinorrhea Tiffany Mathias, BS,1 Joshua Levy, MD,1 Adil Fatakia, MD,2 Edward D. McCoul, MD3,4 1Department of Otolaryngology – Head and Neck Surgery, Tulane University School of Medicine, New Orleans, LA 2ENT New Orleans, West Jefferson Physician Center, Marrero, LA 3Department of Otorhinolaryngology, Ochsner Clinic Foundation, New Orleans, LA 4The University of Queensland School of Medicine, Ochsner Clinical School, New Orleans, LA Background: Cerebrospinal fluid (CSF) rhinorrhea, when left untreated, can lead to meningitis and other serious complications. Treatment traditionally has entailed an open craniotomy, although the paradigm has now evolved to encompass endoscopic procedures. Trauma, both accidental and iatrogenic, causes the majority of leaks, and trauma involving skull base and facial fractures is most likely to cause CSF rhinorrhea. Diagnosis is aided by biochemical assay and imaging studies. Methods: We reviewed the literature and summarized current practice regarding the diagnosis and management of CSF rhinorrhea. Results: Management of CSF leaks is dictated by the nature of the fistula, its location, and flow volume. Control of elevated intracranial pressure may require medical therapy or shunt procedures. Surgical reconstruction utilizes a graduated approach involving vascularized, nonvascularized, and adjunctive techniques to achieve closure of the CSF leak. Endoscopic techniques have an important role in select cases. Conclusion: An active surgical approach to closing CSF leaks may provide better long-term outcomes in some patients compared to more conservative management. Keywords: Cerebrospinal fluid, cerebrospinal fluid leak, cerebrospinal fluid rhinorrhea, endoscopy, skull base Address correspondence to Edward D.
    [Show full text]
  • AHA/ASA Scientific Statement Recommendations for The
    AHA/ASA Scientific Statement Recommendations for the Management of Cerebral and Cerebellar Infarction with Swelling A Statement for Healthcare Professionals from the American Heart Association/American Stroke Association The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists Writing Committee Eelco F. M. Wijdicks, MD, PhD, FAHA, FACP, Chair*; Kevin N. Sheth, MD, FAHA, Co- Chair*; Bob S. Carter, MD, PhD; David M. Greer, MD, MA, FAHA, FCCM; Scott E. Kasner, MD, FAHA; W. Taylor Kimberly, MD, PhD; Stefan Schwab, MD; Eric E. Smith, MD, MPH, FAHA; Rafael J. Tamargo, MD, FACS, FAANS; Max Wintermark, MD, MAS On behalf of the American Heart Association Stroke Council Endorsed by American Academy of Neurology, American Association of Neurological Surgeons and Congress of Neurological Surgeons, and the Neurocritical Care Society Stroke Council Professional Education Committee This slide presentation was developed by a member of the Stroke Council Professional Education Committee. Kevin N. Sheth, MD, FAHA 2 ©2014 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. Citation Information Key words included in the paper: AHA scientific statements; cerebral swelling; cerebral edema; cerebellar infarct; decompressive craniectomy deterioration; medical management; prognosis; stroke 3 ©2014 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. Applying classification of recommendations and levels of evidence 4 ©2014 American Heart Association,
    [Show full text]
  • End-Of-Life Care for Brain Tumor Patients Manual for Health Care Providers
    End-of-Life Care for Brain Tumor Patients Manual for Health Care Providers AUTHORS: Susan M. Chang, MD Erin Dunbar, MD Virginia Dzul-Church, MD Laura Koehn, MD Margaretta S. Page, RN, MS Neuro-Oncology Gordon Murray Caregiver Program UNIVERSITY OF CALIFORNIA, SAN FRANCISCO End-of-Life Care for Brain Tumor Patients Manual for Health Care Providers CONTENTS: INTRODUCTION . 1 Neuroanatomy .............................. 2 THE USE OF STEROIDS . 3 Role of Steroids .............................. 3 Managing Steroids ........................... 4 Side Effects ................................. 4 SYMPTOM MANAGEMENT . 7 Drowsiness ................................. 8 Headaches.................................. 10 Focal Neurological Symptoms .................. 11 Cognitive, Behavioral, and Emotional Changes ..... 13 Seizures .................................... 16 Delirium .................................... 22 Dysphagia .................................. 25 SOCIAL ISSUES . 27 Children in the Home ......................... 28 Caregiver Concerns........................... 29 CONCLUSION . 31 Introduction he goal of this manual is to provide an overview of what health professionals may expect, as well as offer guidance, in caring for someone with a progressive, T life-threatening brain tumor, with a particular focus on end- of-life issues. Although some of the problems brain tumor patients experience at the end of life are common with many other forms of cancer, there is a subset of challenging problems unique to patients with brain tumors. In fact, the end-of-life phase for brain tumor patients tends to have a different course than general cancer patients. The intent of this manual is to suggest recommendations regarding disease-specific symptoms. Over time, recommendations will likely change as new supportive treatments are incorporated into clinical care. We understand that each patient’s situation is unique and that the end of life is different for each patient.
    [Show full text]
  • Predicting Cerebral Edema in Ischemic Stroke Patients
    Neurological Sciences (2019) 40:745–752 https://doi.org/10.1007/s10072-019-3717-y ORIGINAL ARTICLE Predicting cerebral edema in ischemic stroke patients Antonio Muscari1,2 & Luca Faccioli3 & Maria Vittoria Lega2 & Andrea Lorusso2 & Marco Pastore Trossello3 & Giovanni M. Puddu1 & Luca Spinardi3 & Marco Zoli1,2 Received: 7 August 2018 /Accepted: 10 January 2019 /Published online: 19 January 2019 # Fondazione Società Italiana di Neurologia 2019 Abstract Objectives To produce a scoring system for predicting the development of edema in ischemic stroke patients without edema on admission. Methods This retrospective study included 572 ischemic stroke patients (73.3 ± 13.0 years, 300 male) without signs of cerebral edema on the first CT scan, which was performed on admission. Another scan was normally performed 3 days later, and subsequently whenever needed. Edema was defined as cerebral hypodensity with compression of lateral ventricles. The main clinical, laboratory, and instrumental variables obtained during the first 24 h were related to the appearance of edema on the CT scans performed after the first one. Results Cerebral edema occurred in 158 patients (27.6%) after a median time of 4 days. The variables independently associated with edema development were (odds ratio, 95% CI) the following: (1) total anterior circulation syndrome (4.20, 2.55–6.93; P < 0.0001), (2) hyperdense appearance of middle cerebral artery (4.12, 2.03–8.36; P = 0.0001), (3) closed eyes (2.53, 1.39–4.60; P =0.002),(4) vomiting (3.53, 1.45–8.60; P = 0.006), (5) lacunar cerebral syndrome (0.36, 0.17–0.77; P = 0.008); and (6) white matter lesions (0.53, 0.33–0.86; P = 0.01).
    [Show full text]
  • Pseudohypoxic Brain Swelling After Elective Lumbar Spinal Surgery: Case Report
    Open Access Case Report DOI: 10.7759/cureus.2454 Pseudohypoxic Brain Swelling After Elective Lumbar Spinal Surgery: Case Report John Dickinson 1 , Derek Kroll 1 , Josh Bentley 2 , Aaron J. Gustin 1 1. Neurological Surgery, Advocate Bromenn Medical Center 2. Neurosurgery, Advocate Health Care Corresponding author: John Dickinson, [email protected] Abstract Pseudohypoxic brain swelling (or the more recent term, postoperative intracranial hypotension-associated venous congestion) is a rare and potentially deadly complication that can occur after routine spine or brain surgery. The mechanism of this injury has been described as a rapid cerebral spinal fluid drainage leading to venous cerebral congestion. The clinical and radiographic findings mimic those found in a patient who has suffered an anoxic brain injury. We present the third reported case of postoperative intracranial hypotension-associated venous congestion following spinal surgery. Categories: Neurology, Neurosurgery, Orthopedics Keywords: spinal surgery, durotomy, cerebral spinal fluid, pseudohypoxic brain injury, pseudohypoxic brain swelling, venous cerebral congestion, postoperative intracranial hypotension-associated venous congestion, pihv, anoxic brain injury Introduction Pseudohypoxic brain swelling (PHBS), also more recently termed, postoperative intracranial hypotension- associated venous congestion (PIHV), is a rare and potentially fatal complication that can occur after uneventful spine or brain surgery. In 2003, Van Roost et al. first described PIHV in a study that reviewed 17 patients who postoperatively developed clinical features mimicking global cerebral hypoxia following the application of subgaleal suction drainage during cranial surgery [1]. In 2011, Parpaley et al. reported the first two cases of PIHV following spinal surgery with the application of epidural suction drainage [2]. To our knowledge, this is the third reported case of PIHV following spinal surgery.
    [Show full text]
  • Management of Cerebral Edema in Acute Liver Failure
    821 Management of Cerebral Edema in Acute Liver Failure Beverley Kok, MBBS1 Constantine J. Karvellas, MD, SM1 1 Division of Gastroenterology (Liver Unit), Department of Critical Address for correspondence Constantine J. Karvellas, MD, SM, FRCPC, Care Medicine, University of Alberta, Edmonton, Canada Division of Gastroenterology (Liver Unit), Department of Critical Care Medicine, University of Alberta, 1-40 Zeidler Ledcor Building, Semin Respir Crit Care Med 2017;38:821–829. Edmonton, Alberta T6G-2Â8, Canada (e-mail: [email protected]). Abstract Advances in medical care of the acute liver failure patient have led to a significant Keywords reduction in mortality related to the condition. Nevertheless, cerebral edema and ► acute liver failure ensuing brain herniation remains one of the top causes of demise in acute liver failure. ► intracranial Controversy remains regarding the utility of invasive intracranial pressure monitoring hypertension as well as usage of novel treatment modalities including therapeutic hypothermia. This ► cerebral edema review provides a brief summary into the pathophysiology and risk factors for ► neuroprotection developing cerebral edema in the context of acute liver failure; this review particularly ► therapeutic provides a practical focus on general management of the patient with established hypothermia cerebral edema as well as specific intracranial pressure-lowering strategies. Acute liver failure (ALF) is a condition wherein a patient with Europe) over a 35-year period showed the proportion of ALF a
    [Show full text]
  • The Role of ICP Monitoring in Meningitis
    NEUROSURGICAL FOCUS Neurosurg Focus 43 (5):E7, 2017 The role of ICP monitoring in meningitis Areej Tariq, MBBS,1 Pedro Aguilar-Salinas, MD,2 Ricardo A. Hanel, MD, PhD,2 Neeraj Naval, MD,2 and Mohamad Chmayssani, MD2 1Department of Neurology, Division of Cerebrovascular Disease and Neurocritical Care, The Ohio State University, Columbus, Ohio; and 2Lyerly Neurosurgery, Baptist Neurological Institute, Jacksonville, Florida Intracranial pressure (ICP) monitoring has been widely accepted in the management of traumatic brain injury. However, its use in other pathologies that affect ICP has not been advocated as strongly, especially in CNS infections. Despite the most aggressive and novel antimicrobial therapies for meningitis, the mortality rate associated with this disease is far from satisfactory. Although intracranial hypertension and subsequent death have long been known to complicate meningitis, no specific guidelines targeting ICP monitoring are available. A review of the literature was performed to understand the pathophysiology of elevated ICP in meningitis, diagnostic challenges, and clinical outcomes in the use of ICP monitoring. https://thejns.org/doi/abs/10.3171/2017.8.FOCUS17419 KEY WORDS meningitis; intracranial pressure; cerebrospinal fluid; critical care HE role of intracranial pressure (ICP) monitoring achieved by exclusively using new antimicrobial agents, has been broadly studied and accepted in the set- but instead from novel management modalities based on ting of traumatic brain injury.5 However, its use in a more complete understanding of the disease process. Tother neurological conditions affecting the ICP is limited, Standard management of severe meningitis, especially especially when managing infections of the CNS. Before with stupor and coma (Glasgow Coma Scale [GCS] score the advent of antimicrobial agents, bacterial meningitis ≤ 8), rarely includes invasive measurement of ICP.
    [Show full text]